Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.
NCT04382508 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2020-05-20
Summary
A weekly questionnaire is sent to patients and parents of patients who are vulnerable for infections. Possible symptoms of COVID19 are asked for and use of healthcare services and testing for COVID19. Weekly reports are being send to the national institutions to update advice given to this group.
Conditions
Interventions
- OTHER
-
Questionnaire
A weekly questionnaire will be filled in
Sponsors & Collaborators
-
Cambridge University Hospitals NHS Foundation Trust
collaborator OTHER -
Alder Hey Children's Hospital
collaborator UNKNOWN -
Birmingham Children's Hospital
collaborator OTHER -
Bradford Royal Infirmary
collaborator OTHER -
Bristol Royal Hospital for Children
collaborator OTHER -
Cardiff and Vale University Health Board
collaborator OTHER_GOV -
Great North Children's Hospital
collaborator UNKNOWN -
Great Ormond Street Hospital for Children NHS Foundation Trust
collaborator OTHER -
Oxford University Hospitals NHS Trust
collaborator OTHER -
Leeds Teaching Hospitals NHS Trust
collaborator UNKNOWN -
Norfolk and Norwich University Hospitals NHS Foundation Trust
collaborator OTHER -
Nottingham Children's Hospital
collaborator UNKNOWN -
Royal Alexandra Children's Hospital
collaborator OTHER -
Royal Hospital for Sick Children, Glasgow
collaborator UNKNOWN -
Royal Manchester Children's Hospital
collaborator UNKNOWN -
Royal Marsden NHS Foundation Trust
collaborator OTHER -
Northern Care Alliance NHS Group
collaborator OTHER -
Royal Sussex County Hospital
collaborator OTHER -
Sheffield Children's NHS Foundation Trust
collaborator OTHER -
St George's University Hospital National Health Service Foundation Trust
collaborator UNKNOWN -
Swansea Bay University Health Board
collaborator OTHER -
University College London Hospitals
collaborator OTHER -
University Hospitals Coventry and Warwickshire National Health Service Trust
collaborator UNKNOWN -
East Lancashire Hospitals National Health Service Trust
collaborator UNKNOWN -
Imperial College Healthcare National Health Service Trust
collaborator UNKNOWN -
National Heatlh Service Ayrshire and Arran
collaborator OTHER_GOV -
University Hospital Southampton NHS Foundation Trust
lead OTHER
Principal Investigators
-
Hans de Graaf, MD · University Hospital Southampton NHS Foundation Trust
Eligibility
- Sex
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-22
- Primary Completion
- 2021-03-21
- Completion
- 2021-03-21
Countries
- United Kingdom
Study Locations
More Related Trials
-
TARGet Kids! COVID-19 Study of Children and Families
NCT04449978 ·Status: COMPLETED
-
Consequences of COVID-19 Infection for Child Health and Wellbeing: Protocol for a Prospective, Observational, Longitudinal Study in Children
NCT05799508 ·Status: UNKNOWN
-
COVID-19 in PID Survey
NCT04459689 ·Status: RECRUITING
-
Seroprevalence of SARS-Cov-2 Antibodies in Children
NCT04347408 ·Status: COMPLETED
-
COVID Infection in Pediatric Surgical Patient
NCT05898529 ·Status: RECRUITING
-
Long-term Effects of COVID-19 in Adolescents
NCT04686734 ·Status: COMPLETED
-
Post COVID-19 Complications in Children
NCT05745974 ·Status: UNKNOWN
-
Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection
NCT04934527 ·Status: COMPLETED ·Phase: PHASE2
-
Systematic Screening for Primary Immunodeficiencies in Patients Admitted for Severe Infection in Pediatric Intensive Care Unit
NCT04990908 ·Status: RECRUITING
-
Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection
NCT04707820 ·Status: COMPLETED ·Phase: NA
-
Clinical Protocol for Convalescent Plasma and Remdesivir Therapy in Nepal
NCT04570982 ·Status: UNKNOWN
-
Safety of Cotrimoxazole in HIV- and HAART-exposed Infants
NCT01086878 ·Status: COMPLETED ·Phase: PHASE4
-
Systematic Screening for Primary Immunodeficiencies in Patients Hospitalized for Severe Infections in Intensive Care.
NCT04356053 ·Status: UNKNOWN
-
SARS-CoV2 Antibodies in Pediatric Patients (COVID-19)
NCT04581148 ·Status: UNKNOWN
-
Immune Response to Anti COVID-19 Vaccine in Immunocompromised Patients: a Cohort Study
NCT04888793 ·Status: COMPLETED
-
Evaluation of Direct Antiviral Treatments Against SARS-CoV-2 in Immunocompromised Patients With Covid-19. A G2i Study, National Multicenter Observational and Retrospective From June 2023 to April 2024
NCT06683937 ·Status: NOT_YET_RECRUITING
-
Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID-19.
NCT04322279 ·Status: TERMINATED
-
Monitoring of the Post-vaccination Immune Response to COVID-19 Among Hospital Staff
NCT04896788 ·Status: UNKNOWN ·Phase: NA
-
Seroprevalence of Infection-induced SARS-CoV-2 Antibodies (COVID-19) in Children
NCT05358626 ·Status: COMPLETED
-
Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients
NCT04852796 ·Status: COMPLETED
-
Multisystem Inflammatory Syndrome In Children at Sohag University Hospital
NCT05382234 ·Status: UNKNOWN
-
In Utero Exposure to SARS-CoV-2 (COVID-19) and Cardiovascular and Metabolic Endpoints in Early Life
NCT04921241 ·Status: COMPLETED
-
Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients
NCT00699868 ·Status: COMPLETED ·Phase: NA
-
Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment of Immunocompromised Patients
NCT05905380 ·Status: UNKNOWN
-
The Long-term Impact of Invasive Meningococcal Disease in Australian Adolescents and Young Adults
NCT03798574 ·Status: COMPLETED